These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU. Pasquini Z; Montalti R; Temperoni C; Canovari B; Mancini M; Tempesta M; Pimpini D; Zallocco N; Barchiesi F J Antimicrob Chemother; 2020 Nov; 75(11):3359-3365. PubMed ID: 32829390 [TBL] [Abstract][Full Text] [Related]
4. Persistent COVID-19 in an Immunocompromised Patient Temporarily Responsive to Two Courses of Remdesivir Therapy. Helleberg M; Niemann CU; Moestrup KS; Kirk O; Lebech AM; Lane C; Lundgren J J Infect Dis; 2020 Sep; 222(7):1103-1107. PubMed ID: 32702095 [TBL] [Abstract][Full Text] [Related]
5. Rapid review for the anti-coronavirus effect of remdesivir. Li Z; Wang X; Cao D; Sun R; Li C; Li G Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648 [TBL] [Abstract][Full Text] [Related]
6. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug? Thalha AMM; Lee YY; Besari A; Omar SFS J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289 [No Abstract] [Full Text] [Related]
7. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516 [No Abstract] [Full Text] [Related]
8. Remdesivir for severe covid-19: a clinical practice guideline. Rochwerg B; Agarwal A; Zeng L; Leo YS; Appiah JA; Agoritsas T; Bartoszko J; Brignardello-Petersen R; Ergan B; Ge L; Geduld H; Gershengorn HB; Manai H; Huang M; Lamontagne F; Kanda S; Kawano-Dourado L; Kurian L; Kwizera A; Murthy S; Qadir N; Siemieniuk R; Silvestre MA; Vandvik PO; Ye Z; Zeraatkar D; Guyatt G BMJ; 2020 Jul; 370():m2924. PubMed ID: 32732352 [TBL] [Abstract][Full Text] [Related]
9. Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. Gonzales-Zamora JA; Quiroz T; Vega AD Medwave; 2020 Aug; 20(7):e7998. PubMed ID: 32876623 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19). Dominguez-Santas M; Diaz-Guimaraens B; Garcia Abellas P; Moreno-Garcia Del Real C; Burgos-Blasco P; Suarez-Valle A J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e536-e537. PubMed ID: 32453865 [No Abstract] [Full Text] [Related]
11. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process. Ison MG; Wolfe C; Boucher HW JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438 [No Abstract] [Full Text] [Related]
12. Delayed Initiation of Remdesivir in a COVID-19-Positive Patient. Hillaker E; Belfer JJ; Bondici A; Murad H; Dumkow LE Pharmacotherapy; 2020 Jun; 40(6):592-598. PubMed ID: 32281114 [TBL] [Abstract][Full Text] [Related]
13. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19. Chua KP; Conti RM JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187 [No Abstract] [Full Text] [Related]
14. Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019. Igbinosa I; Miller S; Bianco K; Nelson J; Kappagoda S; Blackburn BG; Grant P; Subramanian A; Lyell DJ; El-Sayed YY; Aziz N Am J Obstet Gynecol; 2020 Nov; 223(5):768-770. PubMed ID: 32771381 [No Abstract] [Full Text] [Related]
15. Use of remdesivir for patients with Covid-19: a review article. Azevedo TCP; Azevedo PCP; Silveira Filho RN; Carvalho ARVS; Cezarotti Filho ML; Barbosa FT; Sousa-Rodrigues CF; Matos-Rocha TJ; Ramos FWDS Rev Assoc Med Bras (1992); 2020 Jun; 66(6):838-841. PubMed ID: 32696862 [TBL] [Abstract][Full Text] [Related]
16. [Remdesivir for patients with severe COVID-19]. Augustin M; Hallek M; Nitschmann S Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086 [No Abstract] [Full Text] [Related]
17. Neonates With SARS-CoV-2 Infection and Pulmonary Disease Safely Treated With Remdesivir. Saikia B; Tang J; Robinson S; Nichani S; Lawman KB; Katre M; Bandi S Pediatr Infect Dis J; 2021 May; 40(5):e194-e196. PubMed ID: 33847299 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C Trials; 2020 May; 21(1):422. PubMed ID: 32448345 [TBL] [Abstract][Full Text] [Related]
19. An Acute Pulmonary Coccidioidomycosis Coinfection in a Patient Presenting With Multifocal Pneumonia With COVID-19. Chang CC; Senining R; Kim J; Goyal R J Investig Med High Impact Case Rep; 2020; 8():2324709620972244. PubMed ID: 33167717 [TBL] [Abstract][Full Text] [Related]
20. Compassionate Use of Remdesivir in Children With Severe COVID-19. Goldman DL; Aldrich ML; Hagmann SHF; Bamford A; Camacho-Gonzalez A; Lapadula G; Lee P; Bonfanti P; Carter CC; Zhao Y; Telep L; Pikora C; Naik S; Marshall N; Katsarolis I; Das M; DeZure A; Desai P; Cao H; Chokkalingam AP; Osinusi A; Brainard DM; Méndez-Echevarría A Pediatrics; 2021 May; 147(5):. PubMed ID: 33883243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]